Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Intangibles (2020 - 2025)

Mereo BioPharma (MREO) has disclosed Intangibles for 5 consecutive years, with $516000.0 as the latest value for Q4 2025.

  • Quarterly Intangibles fell 19.75% to $516000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $516000.0 through Dec 2025, down 19.75% year-over-year, with the annual reading at $516000.0 for FY2025, 19.75% down from the prior year.
  • Intangibles for Q4 2025 was $516000.0 at Mereo BioPharma, down from $643000.0 in the prior quarter.
  • The five-year high for Intangibles was $33.1 million in Q4 2021, with the low at $470000.0 in Q2 2025.
  • Average Intangibles over 4 years is $4.0 million, with a median of $721000.0 recorded in 2024.
  • The sharpest move saw Intangibles skyrocketed 1947.95% in 2021, then tumbled 45.73% in 2025.
  • Over 4 years, Intangibles stood at $33.1 million in 2021, then tumbled by 96.71% to $1.1 million in 2023, then plummeted by 40.96% to $643000.0 in 2024, then fell by 19.75% to $516000.0 in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $516000.0, $643000.0, and $470000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.